Helicobacter pylori and pancreatic cancer risk: A meta-analysis based on 2,049 cases and 2,861 controls

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 11, 2014, Pages 4449-4454

  Wang, Yin ^a   Zhang, Fu Cheng ^b   Wang, Yao Jun ^b  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b Jinan Military Command ^*  (China)

Author keywords

Helicobacter pylori; Meta analysis; Pancreatic cancer; Risk

Indexed keywords

CASE CONTROL STUDY; COMPLICATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; MICROBIOLOGY; PANCREATIC NEOPLASMS; RISK; RISK FACTOR;

CASE-CONTROL STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PANCREATIC NEOPLASMS; RISK; RISK FACTORS;

EID: 84903740787     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.11.4449     Document Type: Article

References (40)

1. Arslan AA, Helzlsouer KJ, Kooperberg C, et al (2010). Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med, 170, 791-802.
2. Atherton JC, Blaser MJ (2009). Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest, 119, 2475-87.
3. Aune D, Greenwood DC, Chan DS, et al (2012). Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol, 23, 843-52.
4. Ben Q, Xu M, Ning X, et al (2011). Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer, 47, 1928-37.
5. Blaser MJ (2006) . Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep, 7, 956-60.
6. Blaser MJ, Chen Y, Reibman J (2008). Does Helicobacter pylori protect against asthma and allergy. Gut, 57, 561-7.
7. Chen Y, Blaser MJ (2007). Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med, 167, 821-7.
8. Chen Y, Blaser MJ (2008). Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis, 198, 553-60.
9. Chen YS, Xu SX, Ding YB, Huang XE, Deng B (2013). Helicobacter pylori infection and the risk of colorectal adenoma and adenocarcinoma: an updated meta-analysis of different testing methods. Asian Pac J Cancer Prev, 14, 7613-9.
10. Correa P, Houghton J (2007). Carcinogenesis of Helicobacter pylori. Gastroenterology, 133, 659-72.
11. de Martel C, Llosa AE, Friedman GD, et al (2008). Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidermal Biomarkers Prev, 17, 1188-94.
12. Duell EJ, Lucenteforte E, Olson SH, et al (2012). Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol, 23, 2964-70.
13. Gawin A, Wex T, Lawniczak M, et al (2012). Helicobacter pylori infection in pancreatic cancer. Pol Merkur Lekarski, 32, 103-7 (in Polish).
14. Guoqin Yu, Gwen Murphy, Angelika Miche et al (2013). Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 22, 2416-19.
15. Handa O, Naito Y, Yoshikawa T (2011). Redox biology and gastric carcinoge n nesis: the role of Helicobacter pylori. Redox Rep, 16, 1-7.
16. Harvey A. , Risch, Lingeng Lu, et al (2014). Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev, 23, 172-8.
17. Higashi H, Tsutsumi R, Fujita A, et al (2002). Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA, 99, 14428-33.
18. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
19. Iodice S, Gandini S, Maisonneuve P, et al (2008). Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg, 393, 535-45.
20. Iodice S, Maisonneuve P, Botteri E, et al (2010). ABO blood group and cancer. Eur J Cancer, 46, 3345-50.
21. Larsson S, Orsini N, Wolk A (2007). Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer, 120, 1993-8.
22. Li D, Tang H, Hassan MM, et al (2011). Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control, 22, 189-97.
23. Lindkvist B, Johansen D, Borgström A, et al (2008). A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer, 8, 321.
24. Loh JT, Shaffer CL, Piazuelo MB, et al (2011). Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemical Biomarkers Prev, 20, 2237-49.
25. Lucenteforte E, La Vecchia C, Silverman D, et al (2012). Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol, 23, 374-82.
26. Lynch SM, Vrie ling A, Lu bin JH, et al (2009). Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol, 170, 403-13.
27. Magruder JT, Elahi D, Andersen DK (2011). Diabetes and pancreatic cancer: chicken or egg? Pancreas, 40, 339-51.
28. Maisonneuve P, Lowenfels AB (2010). Epidemiology of pancreatic cancer: an update. Dig Dis, 28, 645-56.
29. Olson SH (2012). Selected medical conditions and risk of pancreatic cancer (review). Mol Carcinog, 51, 75-97.
30. Peek RM, Blaser MJ (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer, 2, 28-37.
31. Raderer M, Wrba F, Kornek G, et al (1997). Association between Helicobacter pylori infection and pancreatic cancer. Oncology, 55, 16-9.
32. Raimondi S, Lowenfels AB, Morselli-Labate AM, et al (2010). Pancreatic cancer in chronic pancreatitis; a etiology, incidence, and early detection. Best Pract Res Clin Gastroenterol, 24, 349-58.
33. Risch HA, Yu H, Lu L, et al (2010). ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst, 102, 502-5.
34. Shimoyama T, Takahashi R, Abe D, et al (2010). Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol, 25 (Suppl 1), S86-9.
35. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al (2001). Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst, 93, 937-41.
36. Tramacere I, Scotti L, Jenab M, et al (2010). Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer, 126, 1474-86.
37. Trikudanathan G, Philip A, Dasanu CA, et al (2011). Association between Helicobacter pylori infection and pancreatic cancer. a cumulative meta-analysis. JOP, 12, 26-31.
38. Wan-Qing Chen, Di Liang, Si-Wei Zhang, et al (2013). Pancreatic cancer incidence and mortality patterns in China, 2009. Asian Pac J Cancer Prev, 14, 7321-4.
39. Wren AM, Bloom SR (2007). Gut hormones and appetite control. Gastroenterology, 132, 2116-30.
40. Xiao M, Wang Y, Gao Y (2013). Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS ONE, 8, e75559.